PVI
ACIU icon

Pura Vida Investments’s AC Immune ACIU Stock Holding History

Pura Vida Investments’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-33,997
Closed -$168K – 227
2021
Q4 		$168K Sell
33,997
-1,003
-3% -$5.83K 0.01% 224
2021
Q3 		$235K Buy
+35,000
New +$251K 0.01% 268

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Pura Vida Investments's ACIU Position: Q1 2022 in Review

Pura Vida Investments sold out of AC Immune (ACIU) in Q1 2022, closing a stake of 33,997 shares — an estimated $168K sold.

Pura Vida Investments first reported a position in ACIU in Q3 2021 and held it in 2 quarters. The position peaked at $235K in Q3 2021. 36 funds tracked by Wall St. Rank hold ACIU as of Q1 2022.

  • Pura Vida Investments reported no remaining AC Immune position as of Q1 2022 after selling out during the quarter.
  • Pura Vida Investments sold 33,997 AC Immune shares in Q1 2022, an estimated $168K.
  • Pura Vida Investments first reported a position in AC Immune in Q3 2021 and held it in 2 quarters.
  • Pura Vida Investments's AC Immune position peaked at $235K in Q3 2021.
  • 36 funds tracked by Wall St. Rank held AC Immune as of Q1 2022.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.